The World Health Organization (WHO) GEP-NEN classification is based on the proliferative index (Ki-67 and mitotic count) and the degree of differentiation (well-differentiated tumours (G1 to G3) and poorly differentiated neuroendocrine carcinomas (NECs)) [10]. This evidence concerns the gene MKI67 and neoplasm.